Influenza vaccination and major adverse vascular events in high-risk patients (Q46599326)

From Wikidata
Jump to navigation Jump to search
scientific article published on 19 June 2012
edit
Language Label Description Also known as
English
Influenza vaccination and major adverse vascular events in high-risk patients
scientific article published on 19 June 2012

    Statements

    Influenza vaccination and major adverse vascular events in high-risk patients (English)
    Ongoing Telmisartan Alone and in Combination With Ramipril Global EndPoint Trial (ONTARGET)
    Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease (TRANSCEND) Investigators

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit